| Literature DB >> 35204153 |
Shuo Wang1,2, Fengming Hu1,2, Qiyu Diao1,2, Shuang Li1, Yan Tu1,2, Yanliang Bi1,2.
Abstract
High-cost milk proteins necessitate cheaper, effective milk replacer alternatives, such as plant proteins. To examine plant protein-based milk replacer's impact on growth performance, serum immune and antioxidant indicators, and liver transcriptome profiles in suckling calves. We assigned 28 newborn Holstein calves (41.60 ± 3.67 kg of body weight at birth) to milk (M) or milk replacer (MR) and starter diets pre-weaning (0-70 d of age) but with the same starter diet post-weaning (71-98 d of age). During the pre-weaning period, compared with the M group, MR group had significantly lower body weight, withers height, heart girth, average daily gain, feed efficiency, serum immunoglobulin (Ig) M concentration, superoxide dismutase concentration, and total antioxidant capacity; whereas they had significantly higher serum aspartate aminotransferase concentration. During the post-weaning period, MR group presented significantly higher average daily gain, alanine transaminase, aspartate aminotransferase, and malonaldehyde concentrations; whereas they had significantly lower serum IgA and IgM concentrations than the M group. Transcriptome analysis revealed 1, 120 and 293 differentially expressed genes (DEGs; MR vs. M group) in the calves from pre- and post-weaning periods, respectively. The DEGs related to xenobiotic and lipid metabolism and those related to energy metabolism, immune function, and mineral metabolism were up- and downregulated, respectively, during the pre-weaning period; during the post-weaning period, the DEGs related to osteoclast differentiation and metabolic pathways showed difference. In this study, compared with M group, MR group had the same growth performance during the overall experimental period; however, MR affected the hepatic metabolism, immune, and antioxidant function of calves. These observations can facilitate future studies on milk replacers.Entities:
Keywords: calf; liver; milk replacer; plant protein; transcriptome
Year: 2022 PMID: 35204153 PMCID: PMC8868243 DOI: 10.3390/antiox11020270
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Ingredient and chemical composition of milk and milk replace.
| Treatment | ||
|---|---|---|
| Items | Milk Powder 1 | Milk Replacer 2 |
| Chemical composition (% of DM except for Dry matter; mean ± SD) | ||
| Dry matter | 96.76 ± 0.61 | 96.32 |
| Gross energy MJ/kg | 24.81 ± 0.41 | 24.62 |
| Crude Protein | 27.01 ± 0.36 | 26.93 |
| Ether extract | 30.67 ± 0.53 | 16.28 |
| Ash | 5.58 ± 0.05 | 5.53 |
| Calcium | 1.06 ± 0.03 | 1.02 |
| Phosphorus | 0.75 ± 0.03 | 0.77 |
1 Milk powder was obtained by drying the fresh whole milk, which was sampled every 15 days. 2 The ingredient compositions are 5% wheat protein powder, 4% rice protein powder, 18% whole soy powder, 6% concentrate whey protein, 22% whole milk power, 20% high protein whey powder, 12% fat powder, 0.2% vitamin complex, 4% Trace elements and mineral complexes, and 8.8% soluble carrier, and the lysine, Threonine, Methionine, essential amino acid, nonessential amino acid of milk replacer are 1.43%, 1.24%, 0.91%, 9.91%, and 15.59%, respectively (% of DM). Per kg milk replacer (DM basis) contains 15,000 IU vitamin A, 5000 IU vitamin D, 50 mg vitamin E, 6.5 mg vitamin B1, 6.5 mg vitamin B2, 6.5 mg vitamin B6, 0.07 mg vitamin B12, 20 mg vitamin B5, 13 mg vitamin B3, 0.1 mg vitamin H, 10 ppm Cu, 100 ppm Fe, 40 ppm Mn, 40 ppm Zn, 0.5 ppm I, 0.3 ppm Se, 0.1 ppm Co.
Growth performance of calves fed milk or milk replacer. (N = 14 per group).
| Treatment (T) 1 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items 4 | MR | M | SEM | T | Days (D) 2 | T × D | P 3 | T × P |
| Pre-weaning (0–70 d) | ||||||||
| DMI of starter feed, kg/d | 0.23 | 0.16 | 0.02 | 0.009 | <0.001 | 0.601 | ||
| DMI of liquid feed, kg/d | 1.00 | 1.05 | 0.01 | 0.043 | <0.001 | 0.622 | ||
| Total DMI 4, kg/d | 1.23 | 1.22 | 0.02 | 0.513 | <0.001 | 0.742 | ||
| ADG, kg/d | 0.83 | 0.92 | 0.02 | 0.007 | <0.001 | 0.461 | ||
| Feed efficiency 5 | 0.67 | 0.76 | 0.03 | <0.001 | <0.001 | 0.731 | ||
| Post-weaning (70–98 d) | ||||||||
| DMI of starter feed, kg/d | 2.79 | 2.28 | 0.10 | <0.001 | <0.001 | 0.231 | ||
| ADG, kg/d | 1.09 | 0.97 | 0.03 | 0.024 | <0.001 | 0.814 | ||
| Feed efficiency | 0.39 | 0.43 | 0.01 | 0.006 | <0.001 | 0.731 | ||
| Overall (0–98 d) | ||||||||
| Total DMI, kg/d | 1.68 | 1.51 | 0.03 | 0.002 | <0.001 | 0.004 | ||
| ADG, kg/d | 0.91 | 0.94 | 0.02 | 0.334 | <0.001 | 0.193 | ||
| Feed efficiency | 0.45 | 0.54 | 0.01 | <0.001 | <0.001 | 0.241 | ||
| Body weight, kg | ||||||||
| Initial (d 0) | 41.4 | 41.9 | 1.65 | 0.781 | ||||
| Weaning (d 70) | 98.2 | 107.4 | 2.83 | 0.004 | ||||
| Final (d 98) | 128.1 | 132.7 | 3.68 | 0.225 | ||||
| Skeletal growth | ||||||||
| Withers height, cm | ||||||||
| Initial (d 0) | 77.7 | 76.0 | 0.93 | 0.072 | ||||
| Weaning (d 70) | 94.6 | 97.2 | 1.13 | 0.026 | ||||
| Final (d 98) | 98.7 | 101.3 | 1.30 | 0.055 | ||||
| Heart girth, cm | ||||||||
| Initial (d 0) | 77.3 | 76.1 | 0.98 | 0.233 | ||||
| Weaning (d 70) | 107.1 | 109.9 | 1.10 | 0.018 | ||||
| Final (d 98) | 116.9 | 118.2 | 1.35 | 0.341 | ||||
| Body length, cm | ||||||||
| Initial (d 0) | 69.8 | 69.4 | 1.06 | 0.702 | ||||
| Weaning (d 70) | 97.3 | 99.4 | 1.04 | 0.131 | ||||
| Final (d 98) | 105.5 | 106.5 | 1.73 | 0.584 | ||||
1 MR = milk replacer; M = milk. 2 For all variables, days of age were used as 14-d period. 3 P = calf phase (pre-weaning vs. post-weaning period). 4 Total DMI = total daily matter intake (starter feed intake + liquid feed intake); 5 Feed efficiency = ADG/Total DMI; Standard error of the mean (SEM).
Serum variables as influenced by feeding milk versus milk replacer to calves. (N = 6 per group).
| Treatment (T) 1 | ||||||
|---|---|---|---|---|---|---|
| Items | MR | M | SEM | T | Days (D) 2 | T × D |
| ALT, U/L | ||||||
| pre-weaning (35–49 d) | 7.5 | 7.1 | 0.99 | 0.524 | 0.979 | 0.621 |
| post-weaning (84–98 d) | 19.9 | 15.2 | 1.05 | 0.035 | 0.837 | 0.179 |
| AST, U/L | ||||||
| pre-weaning (35–49 d) | 121.6 | 91.5 | 2.88 | 0.028 | 0.778 | 0.632 |
| post-weaning (84–98 d) | 183.2 | 148.7 | 4.23 | 0.036 | 0.081 | 0.712 |
| ALP, U/L | ||||||
| pre-weaning (35–49 d) | 159.6 | 149.4 | 7.93 | 0.205 | 0.730 | 0.453 |
| post-weaning (84–98 d) | 188.1 | 186.1 | 11.49 | 0.693 | 0.334 | 0.818 |
| IgG, g/L | ||||||
| pre-weaning (35–49 d) | 9.9 | 10.2 | 0.50 | 0.942 | 0.706 | 0.579 |
| post-weaning (84–98 d) | 12.7 | 12.3 | 0.44 | 0.994 | 0.206 | 0.765 |
| IgA, g/L | ||||||
| pre-weaning (35–49 d) | 1.3 | 1.6 | 0.04 | 0.571 | 0.002 | 0.442 |
| post-weaning (84–98 d) | 1.1 | 1.2 | 0.02 | 0.028 | 0.004 | 0.668 |
| IgM, g/L | ||||||
| pre-weaning (35–49 d) | 2.1 | 2.8 | 0.06 | 0.012 | 0.725 | 0.971 |
| post-weaning (84–98 d) | 2.1 | 2.7 | 0.06 | 0.001 | 0.819 | 0.715 |
| SOD, U/mL | ||||||
| pre-weaning (35–49 d) | 85.3 | 99.1 | 3.06 | 0.045 | 0.679 | 0.391 |
| post-weaning (84–98 d) | 128.3 | 125.8 | 2.26 | 0.278 | 0.138 | 0.442 |
| MDA, nmol/mL | ||||||
| pre-weaning (35–49 d) | 7.2 | 5.9 | 0.23 | 0.035 | 0.673 | 0.229 |
| post-weaning (84–98 d) | 4.7 | 4.2 | 0.11 | 0.015 | 0.714 | 0.814 |
| GSH-PX, U/mL | ||||||
| pre-weaning (35–49 d) | 824 | 837 | 26.48 | 0.595 | 0.115 | 0.415 |
| post-weaning (84–98 d) | 1173 | 1202 | 30.46 | 0.698 | <0.001 | 0.458 |
| T-AOC, U/mL | ||||||
| pre-weaning (35–49 d) | 6.2 | 7.1 | 0.16 | 0.005 | 0.541 | 0.818 |
| post-weaning (84–98 d) | 9.8 | 10.3 | 0.42 | 0.103 | 0.328 | 0.643 |
| CAT, U/mL | ||||||
| pre-weaning (35–49 d) | 8.6 | 8.5 | 0.33 | 0.596 | 0.333 | 0.992 |
| post-weaning (84–98 d) | 11.4 | 12.1 | 0.48 | 0.286 | 0.215 | 0.710 |
1 MR = milk replacer; M = milk. 2 For all variables, days of age were used as 8-d period. Standard error of the mean (SEM), Serum immunoglobulin (Ig), aspartate aminotransferase (AST), glutamic-pyruvic transaminase (ALT), alkaline phosphatase (ALP), total antioxidant capacity (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), malondialdehyde (MDA), catalase (CAT).
Figure 1Gene expression between milk and milk replacer groups. (A) The principal component analysis (PCA) of all genes in liver between MBW and RBW. (B) The principal component analysis (PCA) of all genes in liver between MAW and RAW. (C) The expression of differentially expressed genes between two groups during pre-weaning period. (D) The expression of differentially expressed genes between two groups during post-weaning period. The red dots indicate upregulated differentially expressed genes and the green dots indicate downregulated differentially expressed genes. The blue dots reveal that there is no difference in the expression of genes between the two groups. MBW (liver samples from the milk group before weaning); RBW (liver samples from the milk replacer group before weaning); MAW (liver samples from the milk group after weaning); RAW (liver samples from the milk replacer after weaning).
Figure 2Enrichment analysis of differentially expressed genes (DEGs). (A,B) The gene interactive network and the enrichment result of Top 1 Module between RBW and MBW. (C,D) The gene interactive network and the enrichment result of Top 2 Module between RBW and MBW. (E,F) The gene interactive network and the enrichment result of Top 3 Module between RBW and MBW. (G,H) The gene interactive network and the enrichment result of Top 4 Module between RBW and MBW. (I) The enrichment result of all DEGs between RAW and MAW. Red represents the upregulated genes and blue represents the downregulated genes in the gene interactive network. Different colors represent different enrichment groups (based on the Cohen’s kappa score) in enrichment analysis. The triangle and circle graph represent the KEGG and GO results, respectively, in the enrichment analysis. MBW (liver samples from the milk group before weaning); RBW (liver samples from the milk replacer group before weaning). MAW (liver samples from the milk group after weaning); RAW (liver samples from the milk replacer group after weaning).
Figure 3Relationship between hub-DEGs and phenotypes, and verification of transcriptome accuracy. (A) The top 10 hub-genes by cytoHubba in the top 200 differentially expressed genes between two groups. Blue genes are the first-stage genes of the hub-genes; (B) Correlation analysis between the apparent indicators and differently expressed genes. The pink color represents a positive correlation, and the blue color represents a negative correlation. The red to blue scale bar running from 1.0 to −1.0 represents r = 1.0 to −1.0. The blank represents p > 0.05. Serum immunoglobulin (Ig), glucose (GLU), triacylglycerol (TG), aspartate aminotransferase (AST), glutamic-pyruvic transaminase (ALT), alkaline phosphatase (ALP), total protein (TP), albumin (ALB), globulin (GLB), total antioxidant capacity (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), malondialdehyde (MDA), serum catalase (Serum CAT); (C) Validation of eight differentially expressed genes using quantitative real-time PCR (qRT-PCR). During pre- and post-weaning period, genes were validated. The mRNA level of each gene was normalized to that of β-actin (n = 4). The ratio of expression in livers of milk replacer calves to milk (Milk replacer/Milk) via RNA-Seq and RT-PCR is shown (n = 1).